A detailed history of Blume Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Blume Capital Management, Inc. holds 99,309 shares of PFE stock, worth $2.66 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
99,309
Previous 74,988 32.43%
Holding current value
$2.66 Million
Previous $2.1 Million 36.99%
% of portfolio
0.66%
Previous 0.52%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$27.7 - $31.39 $673,691 - $763,436
24,321 Added 32.43%
99,309 $2.87 Million
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $232,265 - $272,172
9,195 Added 13.98%
74,988 $2.1 Million
Q1 2024

May 02, 2024

BUY
$25.89 - $29.73 $428,945 - $492,566
16,568 Added 33.66%
65,793 $1.83 Million
Q4 2023

May 01, 2024

BUY
$26.13 - $33.94 $600,990 - $780,620
23,000 Added 87.7%
49,225 $1.42 Million
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $600,990 - $780,620
23,000 Added 87.7%
49,225 $1.42 Million
Q3 2023

May 01, 2024

BUY
$32.09 - $37.51 $476,215 - $556,648
14,840 Added 130.35%
26,225 $869,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $476,215 - $556,648
14,840 Added 130.35%
26,225 $869,000
Q2 2023

May 01, 2024

BUY
$36.12 - $41.79 $315,688 - $365,244
8,740 Added 330.43%
11,385 $417,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $315,688 - $365,244
8,740 Added 330.43%
11,385 $417,000
Q1 2023

May 01, 2024

SELL
$39.39 - $51.28 $1.83 Million - $2.39 Million
-46,580 Reduced 94.63%
2,645 $107,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $3,131 - $4,087
-75 Reduced 2.76%
2,645 $135,000
Q3 2022

Nov 15, 2022

SELL
$43.76 - $53.42 $1,312 - $1,602
-30 Reduced 1.09%
2,720 $119,000
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $31,407 - $37,239
-675 Reduced 19.71%
2,750 $144,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $3.95 Million - $4.9 Million
-86,380 Reduced 96.19%
3,425 $177,000
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $1.14 Million - $1.68 Million
-27,480 Reduced 23.43%
89,805 $5.3 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $205,159 - $263,545
-5,227 Reduced 4.27%
117,285 $5.04 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $1.3 Million - $1.47 Million
36,098 Added 41.77%
122,512 $4.8 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $2.68 Million - $3.03 Million
80,140 Added 1277.34%
86,414 $3.13 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $3,191 - $3,702
-100 Reduced 1.57%
6,274 $222,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $197,594 - $217,672
6,374
6,374 $228,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Blume Capital Management, Inc. Portfolio

Follow Blume Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blume Capital Management, Inc. with notifications on news.